Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program
Authors:
- Solveig HofvindSHSolveig Hofvind
- Ragnhild SørumRSRagnhild Sørum
- Steinar ThoresenSTSteinar Thoresen
- 1 January 2008
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 47 (2) , 225-231
Abstract
Randomized controlled trials and service screening programs have shown that breast cancer screening reduces the mortality from the disease. Several years of monitoring are needed to prove such an effect. In the meantime attention should be paid to early surrogate measures, such as histopathological tumor characteristics. The Norwegian Breast Cancer Screening Program started November 1995. This study compares incidence, prognostic tumor characteristics and surgical treatment in breast cancer cases diagnosed in the pre-screening (1987-1995, n=2 618) and screening period (1996-2004, n=5 417), in women aged 50-69 years, residing in the first four counties implementing the screening program. The screening period is divided into those invited versus those not invited to the screening program, and those exposed (participants) versus those not exposed to the program (non-participants). The incidence of invasive breast cancer rose from 170 per 100 000 women years (wy) in 1987 to 355 per 100 000 wy in 1997. The proportion of DCIS was 5% in the pre-screening period, and 14% in the screening period. Tumors 20 mm or less were diagnosed in 56% of the invasive cases in the pre-screening period, in 74% of the invited, and in 77% of the exposed women. The relative risk of diagnosing breast cancer with metastases was 0.85 (95% CI 0.84-0.87) for invited and 0.82 (95% CI 0.81-0.84) for exposed women, relative to those diagnosed in the pre-screening period. Ablation was performed in 85% of the invasive cases diagnosed in the pre-screening period, and in 45% of the cases in the screening period. Breast cancer diagnosed in the screening period had prognostically favorable tumor characteristics compared to breast cancer diagnosed in the pre-screening period. Implementation of organized population based screening and the time trend are considered possible reasons.Keywords
This publication has 17 references indexed in Scilit:
- Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in ItalyBreast Cancer Research, 2006
- Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyThe Lancet Oncology, 2006
- Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up studyBMJ, 2006
- Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screensInternational Journal of Cancer, 2006
- Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort studyBMJ, 2005
- Do the results of the process indicators in the Norwegian breast cancer screening program predict future mortality reduction from breast cancer?Acta Oncologica, 2004
- Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort studyBMJ, 2004
- Gauging the impact of breast carcinoma screening in terms of tumor size and death rateCancer, 2003
- Long-term effects of mammography screening: updated overview of the Swedish randomised trialsThe Lancet, 2002
- Aggressiveness of screen-detected breast cancersThe Lancet, 1995